armatapharma.com (ARMP) Company Total Revenue

armatapharma.com - graphic logo of issuer ARMP

Armata Pharmaceuticals (ARMP) sales volume reflects the challenges of bringing bacteriophages to market and a capital deficit, while 0.01 captures the current state of this parameter. The Innoviva fund ensures business stability through strict expense control. Projects are shielded from sanctions by their humanitarian status, and the localization of development in the US guarantees the reliability of all supply chains.

ARMP - Armata Pharmaceuticals, Inc. Revenue and Sales Volume over the range 07/04/2022 - 11/15/2026

Comprehensive metric breakdowns and analytics for Armata Pharmaceuticals Inc (ARMP)

- share price and expert price forecast:
Price Performance Chart armatapharma.com|ARMP - Price Target Chart
- market capitalization details:
Market Value Armata Pharmaceuticals Inc|ARMP - Enterprise Value
- book value of equity indicators:
Net Assets per Single Share Armata Pharmaceuticals|ARMP - Book Capitalization|Market-to-Book Ratio armatapharma.com|ARMP - Aggregate Company Assets
- debt and solvency information:
Total Debt to Capital Coefficient Armata Pharmaceuticals|ARMP - Long-Term Debt to Capital|Short-Term Debt to Capital Armata|ARMP - Company Debts|Debt to Net Assets Ratio Armata Pharma|ARMP - Company Long-Term Debt|Company Current Liabilities Armata Pharmaceuticals|Quick Ratio armatapharma.com
- earnings and market ratios statistics:
ARMP - Net Income|Future Net Profit Armata Pharmaceuticals|ARMP - P/E Multiple|Forward P/E Multiple Armata Pharma|ARMP - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation Armata Pharma|ARMP - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Armata Pharmaceuticals|ARMP - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months armatapharma.com|ARMP - Earnings growth in current year|Earnings growth forecast for next year Armata Pharmaceuticals
- company sales and revenue statistics:
ARMP - Company Revenue|Company Future Revenue armatapharma.com|ARMP - Price-to-Revenue Ratio|Forward Price-to-Revenue Multiple Armata Pharmaceuticals Inc|ARMP - Sales Growth YoY (TTM)
Comprehensive company analysis:armatapharma.com - ARMP
Manufactured product of Armata Pharmaceuticals, Inc.

Daily sales capture business scaling dynamics, allowing for the prompt detection of stagnating growth rates. An analysis of the company's current sales level visualizes cash flow from core operations in real time. This metric aggregates all confirmed transactions, determining the issuer's market reach. For Armata Pharmaceuticals (ARMP), this figure remains low due to the clinical status of its developments. Commercial growth will only occur following the creation of unique agents to combat superbugs.

Analysis of competing companies

ACXP: Company Sales Revenue